Literature DB >> 18815823

Short- and long-term effects of CPAP on upper airway anatomy and collapsibility in OSAH.

Luciano Corda1, Stefania Redolfi, Luigi Taranto Montemurro, Giuseppe E La Piana, Enrica Bertella, Claudio Tantucci.   

Abstract

RATIONALE AND AIM: In obstructive sleep apnea hypopnea (OSAH) patients, an increase of upper airway (UA) collapsibility has been described together with a reduced UA caliber due to inflammation, edema, and fat accumulation in pharyngeal walls. CPAP is the main treatment of OSAH and acts mechanically by increasing pressure inside UA. The aim of this study was to assess the short- and long-term effects of CPAP on UA caliber and collapsibility in severe OSAH patients. PATIENTS AND METHODS: Ten obese patients (nine male, age 55+/- 9 yr, BMI 35.1 +/- 6.1, Epworth sleepiness scale 12.3 +/- 3.6 point, AHI 58.8 +/- 27.1) had measurements of oropharingeal junction area (OPJ), mean pharyngeal area (APmean), maximal pharyngeal area (APmax) by acoustic pharyngometry and determination of expired volume in the first 0.5 s after the application at the mouth of -5 cmH(2)O negative expiratory pressure (V,NEP(0.5)) during wakefulness in the supine position under basal conditions (baseline) and after 1 week and 6 months of CPAP treatment.
RESULTS: OPJ was 0.74 +/- 0.28 cm(2) at baseline, 0.90 +/- 0.24 cm(2) after 1 week and 1.05 +/- 0.31 cm(2) after 6 months (1 week and 6 months vs baseline p < 0.05). APmax was 2.28 +/- 0.74 cm(2) at baseline, 2.79 +/- 0.90 cm(2) after 1 week and 2.94 +/- 0.33 cm(2) after 6 months (1 week and 6 months vs baseline p < 0.05). APmean was 1.43 +/- 0.46 cm(2) at baseline, 1.82 +/- 0.45 cm(2) after 1 week and 1.94 +/- 0.35 cm(2) after 6 months (1 week vs baseline p < 0.01; 6 months vs baseline; p < 0.05). V,NEP(0.5) was 290 +/- 73 mL at baseline, 291 +/- 65 mL after 1 week and 338 +/- 67 mL after 6 months (6 months vs baseline p < 0.05; 1 week vs 6 months p < 0.01).
CONCLUSIONS: Our data suggest that CPAP treatment might be effective in OSAH patients not only by causing a mechanical splint of UA but also by inducing an improvement on anatomical (early) and functional (later on) aspects of UA that can be observed during wakefulness.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815823     DOI: 10.1007/s11325-008-0219-1

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  36 in total

Review 1.  Pathogenesis of obstructive sleep apnea.

Authors:  Clodagh M Ryan; T Douglas Bradley
Journal:  J Appl Physiol (1985)       Date:  2005-12

2.  Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome.

Authors:  I L Mortimore; P Kochhar; N J Douglas
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Awake flow limitation with negative expiratory pressure in sleep disordered breathing.

Authors:  R Tamisier; B Wuyam; I Nicolle; J L Pépin; O Orliaguet; C P Perrin; P Lévy
Journal:  Sleep Med       Date:  2005-01-24       Impact factor: 3.492

4.  Predictive value of Kushida index and acoustic pharyngometry for the evaluation of upper airway in subjects with or without obstructive sleep apnea.

Authors:  Dae Gun Jung; Hae Young Cho; Ronald R Grunstein; Brendon Yee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

5.  Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares.

Authors:  C E Sullivan; F G Issa; M Berthon-Jones; L Eves
Journal:  Lancet       Date:  1981-04-18       Impact factor: 79.321

6.  Collapsibility of the nasopharyngeal airway in obstructive sleep apnea.

Authors:  P M Suratt; R F McTier; S C Wilhoit
Journal:  Am Rev Respir Dis       Date:  1985-11

7.  Magnetic resonance imaging of the upper airway in obstructive sleep apnea before and after chronic nasal continuous positive airway pressure therapy.

Authors:  C F Ryan; A A Lowe; D Li; J A Fleetham
Journal:  Am Rev Respir Dis       Date:  1991-10

8.  Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging.

Authors:  Richard J Schwab; Michael Pasirstein; Robert Pierson; Adonna Mackley; Robert Hachadoorian; Raanan Arens; Greg Maislin; Allan I Pack
Journal:  Am J Respir Crit Care Med       Date:  2003-05-13       Impact factor: 21.405

9.  Pharyngeal cross-sectional area in normal men and women.

Authors:  I G Brown; N Zamel; V Hoffstein
Journal:  J Appl Physiol (1985)       Date:  1986-09

10.  Upper airway dynamics during negative expiratory pressure in apneic and non-apneic awake snorers.

Authors:  A Ferretti; P Giampiccolo; S Redolfi; S Mondini; F Cirignotta; A Cavalli; C Tantucci
Journal:  Respir Res       Date:  2006-03-30
View more
  18 in total

1.  Improvement in sleep apnoea associated with switch from simvastatin to pravastatin.

Authors:  Stephanie Cham; Komaldeep Gill; Sabrina Koperski; Beatrice Alexandra Golomb
Journal:  BMJ Case Rep       Date:  2009-09-01

2.  Influence of interface and position on upper airway collapsibility assessed by negative expiratory pressure.

Authors:  Raquel Pastrello Hirata; Fabiane Kayamori; Fabiola Schorr; Henrique Takachi Moriya; Salvatore Romano; Giuseppe Insalaco; Eloisa Gebrim; Luis Vicente Franco de Oliveira; Pedro Rodrigues Genta; Geraldo Lorenzi-Filho
Journal:  Sleep Breath       Date:  2017-01-07       Impact factor: 2.816

Review 3.  Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea.

Authors:  Laura H White; T Douglas Bradley
Journal:  J Physiol       Date:  2012-12-10       Impact factor: 5.182

4.  Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea.

Authors:  David W Carley; Bharati Prasad; Kathryn J Reid; Roneil Malkani; Hryar Attarian; Sabra M Abbott; Boris Vern; Hui Xie; Chengbo Yuan; Phyllis C Zee
Journal:  Sleep       Date:  2018-01-01       Impact factor: 5.849

5.  Tongue stiffness is lower in patients with obstructive sleep apnea during wakefulness compared with matched control subjects.

Authors:  Elizabeth C Brown; Shaokoon Cheng; David K McKenzie; Jane E Butler; Simon C Gandevia; Lynne E Bilston
Journal:  Sleep       Date:  2015-04-01       Impact factor: 5.849

Review 6.  Cardiorespiratory interaction with continuous positive airway pressure.

Authors:  Martino F Pengo; Sara Bonafini; Cristiano Fava; Joerg Steier
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

7.  CPAP interface: satisfaction and side effects.

Authors:  Adel Bachour; Pirjo Vitikainen; Paula Virkkula; Paula Maasilta
Journal:  Sleep Breath       Date:  2012-07-05       Impact factor: 2.816

8.  Effects of continuous positive airway pressure on apnea-hypopnea index in obstructive sleep apnea based on long-term compliance.

Authors:  Boris A Stuck; Sarah Leitzbach; Joachim T Maurer
Journal:  Sleep Breath       Date:  2011-05-19       Impact factor: 2.816

9.  The effect of obstructive sleep apnea syndrome and continuous positive airway pressure treatment on voice performance.

Authors:  Doğan Atan; Kürşat Murat Özcan; Aykut İkincioğulları; Sabri Köseoğlu; Mehmet Ali Çetin; Serdar Ensari; Hüseyin Dere
Journal:  Sleep Breath       Date:  2014-12-09       Impact factor: 2.816

10.  Determinants of ventilatory instability in obstructive sleep apnea: inherent or acquired?

Authors:  Andrea Loewen; Michele Ostrowski; John Laprairie; Raj Atkar; January Gnitecki; Patrick Hanly; Magdy Younes
Journal:  Sleep       Date:  2009-10       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.